Hemophagocytic syndrome following haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide
- 30 November 2015
- journal article
- Published by Springer Nature in International Journal of Hematology
- Vol. 103 (2) , 234-242
Abstract
Hemophagocytic syndrome (HPS) is a rare but serious complication after allogeneic transplantation which has been reported to be particularly high after unrelated cord blood transplantation. We report on the incidence, risk factors and outcome of HPS in 51 patients (age 2–64 years) after haploidentical peripheral blood stem cell (PBSC) transplantation with post-transplantation cyclophosphamide (PTCY). The incidence of HPS was 12.2 %, occurring at a median of 18 days. The non-relapse mortality in patients with HPS was 83.3 % compared to 11.6 % in patients without HPS. Complete donor chimerism was documented in all patients with HPS. Definite infective etiology was identified in two patients only. The others were refractory to multiple lines of treatment and 3 patients underwent a second transplant. Even though the symptoms and biochemical markers of HPS showed prompt response in 2/3 patients undergoing a second allograft, they succumbed to infections before haematological recovery. The others succumbed to multi-organ failure or infections. Age < 10 years, transplantation for non-malignant disease and high CD34 content of the graft were identified as risk factors for HPS. Considering the fact that post-transplant HPS is usually a refractory and fatal condition, we discuss further attempts at deciphering the pathogenesis, developing modalities to prevent this complication and improve the outcome.Keywords
This publication has 36 references indexed in Scilit:
- Clinical significance of hemophagocytosis in BM clot sections during the peri-engraftment period following allogeneic hematopoietic SCTBone Marrow Transplantation, 2011
- Molecular basis of familial hemophagocytic lymphohistiocytosisHaematologica, 2010
- High incidence of haemophagocytic syndrome following umbilical cord blood transplantation for adultsBritish Journal of Haematology, 2009
- Toxoplasmosis with hemophagocytic syndrome after bone marrow transplantation: diagnosis at autopsyTransplant Infectious Disease, 2008
- Maternal T-cell Engraftment Associated With Severe Hemophagocytosis of the Bone Marrow in Untreated X-linked Severe Combined ImmunodeficiencyJournal of Pediatric Hematology/Oncology, 2008
- Successful engraftment by second cord blood transplantation with reduced-intensity conditioning after graft rejection due to hemophagocytic syndrome following initial CBTBone Marrow Transplantation, 2007
- Origin of macrophages involved in the development of allogeneic hematopoietic stem cell transplantation-associated hemophagocytic syndrome: observations on a patient with juvenile myelomonocytic leukemiaBone Marrow Transplantation, 2007
- Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.Blood, 2007
- Epstein–Barr virus-associated haemophagocytic lympho-histiocytosis after stem cell transplantationBone Marrow Transplantation, 2006
- Hyperacute GVHD and emergence of peripheral CD3+CD56+ T cells and activated natural killer cells are useful markers for early diagnosis of post-transplant hemophagocytic syndromeBone Marrow Transplantation, 2005